August 2016 GEDSA Position Statement
As a summary of previous Position Statements, GEDSA re-emphasizes recommendations saying, “Performance testing conducted by an accredited third party lab and usability studies conducted throughout the world confirm the ENFit LDT syringe when used as instructed:
- Delivers an accurate dose substantially equivalent with current male orientated enteral/oral syringes.
- Outperforms existing female (reverse) orientated syringes.
- Fits into current practice and maintains compatibility with other ENFit devices
Furthermore, the August GEDSA Position Statement recommends: “GEDSA and its supporting organizations including the Joint Commission, ISMP, ASHP, ASPEN, NHS, and EPSG encourage manufacturers to introduce enteral devices with ENFit connectors, and healthcare facilities to:
- Adopt feeding systems with ENFit connectors as soon as possible.
- Use ENFit LDT syringes to ensure accurate dose delivery of small volumes.
- Work with your supplier representative and distributor network to understand their specific timing and product availability for transition.
- Confirm syringe suppliers have adequate supplies of standard and LDT ENFit syringes before converting to ENFit feeding tubes”
A new and significant recommendation is included by GEDSA:
“In order to obtain the requisite dose accuracy, manufacturers of ENFit LDT syringes should specify in their instructions for use and labeling that the syringe user should remove fluid that lies outside of the fluid path. The area between the male lumen and the outer ring (the “moat”) is not part of the fluid path and should be free of fluid. For settings that require highly accurate low volume doses, an ENFit LDT Syringe is recommended. The ENFit LDT syringe tip design satisfies the performance expectations for dose accuracy, dead space, and tolerance on graduated capacity."
July 2016 GEDSA Position Statement
According to GEDSA, “to ensure small volume dosing accuracy, syringe sizes of 5 mL or smaller may require an ENFit Low Dose Tip Syringe design.” NeoMed is the only ENFit vendor offering a comprehensive line of ENFit Low Dose Tip syringes from 0.5 mL to 6 mL necessary to comply with GEDSA’s guidance document recommendations. Choosing a vendor that does not offer a wide range of ENFit Low Dose Tip syringe sizes (including amber and clear) risks systematic dosing inaccuracies beyond the acceptable range for medication delivery.
April 2016 ENFit Low Dose Tip Syringe Review
- On April 13, 2016, GEDSA made available a summary of the performance testing for the low dose syringe tip design.
- The summary of independent data validates that the NeoMed syringe design meets or exceeds the delivery accuracy of existing oral syringes in the marketplace.
March 2017 ECRI ENFit Alert and Guidance
ECRI Institute, an independent nonprofit organization that researches the best approaches to improving patient care, released an Alert and Guidance on preventing enteral tubing misconnections Critical Notice–Avoid Fatal Misconnections with ENFit-compliant Feeding Tube Connectors. Included in the executive summary, ECRI states “ECRI Institute believes that facilities should move to the new connectors as soon as practicable—ideally, by the end of 2017.” As an organization committed to patient safety initiatives, this timeline will have substantial influence in all hospital transition timelines. ECRI also states:
"There are many different styles, sizes, and configurations of enteral feeding devices produced by multiple manufacturers. The use of ENFit connectors will standardize the connection between all enteral devices, helping to ensure that enteral connectors will fit only with each other, and not with other connector types."